CE Mark Gives SynCardia Systems, Inc. Control over Last Critical Component for SynCardia Heart ManufacturingContinue reading
Category Archives: AZBio News
Job Alert: Clinical Coordinator/Technical Writer at VisionGate
Clinical Coordinator/Technical Writer
VisionGate Corporation
275 N. Gateway Dr. Phoenix, AZ 85034
VisionGate produces the Cell-CT™, the world’s first 3D cellular imaging device based upon optical projection tomography, which renders cells with sub-micron, isometric resolution. Based on 3D images of cells from sputum, VisonGate aims to improve patient health with the world’s first, non-invasive, diagnostic test for early lung cancer detection: LuCED™. VisionGate is expanding its team in Phoenix that will carry the development and commercialization of its products forward.
Position Summary
VisionGate is currently commercializing its LuCED test for early detection of lung cancer. We are also partnering with several institutions locally and internationally who will supply study specimens that will be used to evaluate the LuCED test. Development of other tests based on the Cell-CT are being considered or are in progress. To facilitate our development and clinical programs we seek to add a staff member who will coordinate these clinical studies. Responsibilities will also involve creation of clinical study protocols and reports, abstracts for publications, and other documentation required in a regulated environment. The position will report to the VisionGate CTO and may develop into a management role. Some travel may be required.
Roles and Responsibilities
- Identify clinical sites who could supply VisionGate with specimens for its development and clinical programs.
- Coordinate work with clinical sites that supply specimens for trials of VisionGate tests.
- Maintain clinical study files.
- Maintain inventory of specimens.
- Insure commitments made in protocols have been fulfilled.
- Aid writing study protocols.
- Aid writing test reports and publications.
Training and Experience
- BS in biology or other science-related major.
- 5 years experience as a clinical study coordinator.
- 2-3 years experience as a technical/clinical writer.
- Status as an author in a peer-reviewed journal desired.
- Excellent oral communications skills.
- Familiarity with CLIA regulations.
- Familiarity with FDA GCP and HSP regulations.
- Experience with operation in an FDA regulated environment.
To apply contact Michael Meyer, meyer@visiongate3d.com
Job Alert: IT Support Engineer at VisionGate
IT Support Engineer
VisionGate Corporation
275 N. Gateway Dr. Phoenix, AZ 85034
VisionGate produces the Cell-CT™, the world’s first 3D cellular imaging device based upon optical projection tomography, which renders cells with sub-micron, isometric resolution. Based on 3D images of cells from sputum, VisonGate aims to improve patient health with the world’s first, non-invasive, diagnostic test for early lung cancer detection: LuCED™. VisionGate is expanding to carry the development and commercialization of its products forward.
Position Summary
VisionGate is currently commercializing its LuCED test for early detection of lung cancer. Development of other tests based on the Cell-CT are being considered or are in progress. To facilitate commercialization of our tests and manage our research IT environment, we seek to add a part-time staff member who will help manage and grow our IT Infrastructure.
Roles and Responsibilities
- Manage in-house servers, update servers as in-house software is released.
- Monitor and troubleshoot networking issues including phone system.
- Manage backups and restores from tapes
- Act as IT helpdesk for in-house and remotely based employees
- Specifying and ordering new IT equipment
- Documentation of procedures
Training and Experience
- Experience with managing Linux / Windows servers
- Experience with networking.
- Experience with phone system a plus, though not necessary.
- Perl or Python programming a plus, though not necessary.
- Excellent written and oral communications skills.
- Strong team and interpersonal skills.
To apply contact Rahul Katdare, katdare@visiongate3d.com
Washington Update for May 2014
The Council of State Bioscience Associations (CSBA) is a confederation of state-based, non-profit trade organizations each governed by its own board of directors. The common mission of the members of the CSBA is to promote public understanding, and to advocate for public policies that support the responsible development of the bioscience industry. These groups are recognized by BIO as affiliate organizations in their respective states. AZBio is Arizona’s Authorized BIO affiliate and a proud member of CSBA.Continue reading
New Frontiers in Heath: Life Science Leaders Gathering to Showcase Innovations at the AZBio Expo on June 19, 2014 in Scottsdale, Arizona
Chandler Arizona, May 5, 2014: The Arizona Bioindustry Association today announced that Arizona’s life science industry will be showcased on June 19, 2014 at the Scottsdale Conference Center and Resort during the AZBio Expo. Continue reading
21st Century Cures Initiative Launches to Pick Up the Pace on BioMedical Innovation
A path to 21st century cures being mapped by the Senate Energy and Commerce CommitteeContinue reading
Flagship Biosciences announces agreement in tissue based companion diagnostics development
Flagship Biosciences’ custom image analysis development leverages Leica Biosystems’ strong installed base in digital pathology
Mayo Clinic launches a philanthropic campaign to raise $3 billion by Dec. 31, 2017
Mayo Clinic launches ‘YOU ARE … THE CAMPAIGN FOR MAYO CLINIC’ to perpetuate medical care research and educationContinue reading
Arizona Commerce Authority Announces Semifinalists in the Spring 2014 Arizona Innovation Challenge
PHOENIX (May 7, 2014) – The Arizona Commerce Authority (ACA) today announced 25 semifinalists in its Spring 2014 Arizona Innovation Challenge (AIC), a bi-annual business plan competition awarding $3 million annually to talented entrepreneurs.Continue reading
TGen and George Mason University announce precision medicine alliance for patients with life-threatening illnesses
$12 million in grants pursued by TGen-George Mason Molecular Medicine Alliance, leveraging institutes’ expertise in genomics and proteomicsContinue reading